Literature DB >> 19010641

Benzodiazepine and antidepressant use in elderly patients with anxiety disorders: a survey of 796 outpatients in Japan.

Hiroyuki Uchida1, Takefumi Suzuki, David C Mamo, Benoit H Mulsant, Toshiaki Kikuchi, Hiroyoshi Takeuchi, Masayuki Tomita, Koichiro Watanabe, Gohei Yagi, Haruo Kashima.   

Abstract

Since the literature on benzodiazepine use in elderly patients with anxiety disorders is limited, a large cross-sectional review of psychotropic prescriptions in 796 patients with neurotic disorders (ICD-10) (age range=11-91 years) was conducted across 30 sites in Japan. Use of benzodiazepine-derivative anxiolytics was approximately 70% in all decades without a group difference. The proportion of subjects who received prescriptions for benzodiazepine-derivative anxiolytics in the absence of antidepressants was higher in older age groups (e.g., 27.7% and 43.2% in the third and sixth decades, respectively). On the other hand, antidepressants were less frequently prescribed in older age groups (e.g., 59.8% and 41.5% in the third and sixth decades, respectively). The very high use of anxiolytics in the elderly, especially in the absence of concomitant antidepressant use, is a cause for concern since they are not a preferred long-term treatment strategy given their adverse effects in the elderly.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19010641     DOI: 10.1016/j.janxdis.2008.10.003

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  6 in total

Review 1.  A tipping point in drug dosing in late-life schizophrenia.

Authors:  Takashi Tsuboi; Takefumi Suzuki; Hiroyuki Uchida
Journal:  Curr Psychiatry Rep       Date:  2011-06       Impact factor: 5.285

Review 2.  New research on anxiety disorders in the elderly and an update on evidence-based treatments.

Authors:  Carmen Andreescu; Daniel Varon
Journal:  Curr Psychiatry Rep       Date:  2015-07       Impact factor: 5.285

Review 3.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

4.  Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment.

Authors:  Yasushi Kawamata; Norio Sugawara; Masamichi Ishioka; Kazutoshi Kubo; Katsuji Suzuki; Akira Fujii; Hanako Furukori; Taku Nakagami; Norio Yasui-Furukori; Kazutaka Shimoda
Journal:  Neuropsychiatr Dis Treat       Date:  2021-06-15       Impact factor: 2.570

5.  Feasibility study of mindfulness-based cognitive therapy for anxiety disorders in a Japanese setting.

Authors:  Mitsuhiro Sado; Sunre Park; Akira Ninomiya; Yasuko Sato; Daisuke Fujisawa; Joichiro Shirahase; Masaru Mimura
Journal:  BMC Res Notes       Date:  2018-09-06

6.  Factors affecting hallucinations in patients with delirium.

Authors:  Masako Tachibana; Toshiya Inada; Masaru Ichida; Norio Ozaki
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.